Mesoblast, Inc.

This study tested whether stem cell infusions could help people with moderate-to-severe Crohn's disease who hadn't responded to standard medications. 330 participants received either stem cells or a placebo through four IV treatments over two weeks. The goal was to see if the ste…

This study tested whether infusions of a type of adult stem cell (called PROCHYMAL) could safely help people with moderate to severe COPD. It involved 62 participants who were randomly assigned to receive either the stem cell treatment or a placebo. The main goals were to check f…

This study tested whether Prochymal, a stem cell therapy, could help patients with severe graft-versus-host disease (GVHD) that hadn't responded to standard treatments. GVHD is a dangerous complication that can occur after a bone marrow transplant, where the donor cells attack th…

This study tested whether an infusion of adult stem cells could help the heart heal better after a person's first heart attack. The goal was to see if this treatment could reduce the risk of developing heart failure later on. Researchers compared the stem cell infusion to a place…

This study tested whether an infusion of donor stem cells could help people with moderate-to-severe Crohn's disease who don't respond to standard treatments. It focused on patients who had already shown some improvement from the cells in a previous trial, checking how long that b…

This study tested whether stem cell injections could protect the body's insulin-producing cells in people recently diagnosed with type 1 diabetes. Researchers gave 63 participants either the stem cell treatment or a placebo to see if it could slow or stop the immune system's atta…

This study tested the safety of giving additional stem cell infusions to people with moderate-to-severe Crohn's disease who had already received an initial round of treatment. The 73 participants received three extra infusions over several months to see if continuing treatment wa…